OLIGOMED will develop a N ext Generation Oligonucleotide (ON) Platform Technology based on combining tailored ONs with smart delivery technology, and optimising ON therapies through testing in medicinal environments.

The project is coordinated by the School of Chemistry, University of Southampton

See here for the press release of the University.